Class Action Seeks Refunds for ‘Worthless’ Picato Gel Linked to Increased Skin Cancer Risk
March 30, 2021 A class action seeks refunds for consumers who bought LEO Pharma’s now-discontinued Picato gel that’s been linked to an increased risk of squamous cell skin cancer.